Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis	Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Urogenital Diseases, calcinosis, calciphylaxis, calcium metabolic disease, chronic renal failure syndrome, kidney disorder, kidney failure, metabolic disease, urinary system disorder	Recruiting	Early phase 1	2026-03-04		NCT04592640

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The First Affiliated Hospital with Nanjing Medical University	319
Westlake University	14

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital	Nanjing	China	2